Celebrating 20 Years of MMS – Advancing therapies through data-led science and partnership Read More
March 12th, 2026
AI in Pharma: Autopilot Is Not the Same as Removing the Pilot
April 16th, 2026
Inside FDA REMS Decision-Making: A Fireside Chat for Sponsors
March 3rd, 2026
Modeling and Simulation in Clinical Trials: A Practical Approach to De-Risking Study Design
February 25th, 2026
Integrating AI and Automation Into Clinical Trial Operations With Discipline and Transparency
February 10th, 2026
A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development
February 5th, 2026
MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions
February 3rd, 2026
January 29th, 2026
Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards
January 27th, 2026
A Practical Guide to Expedited Regulatory Pathways
What Regulators Want to See in Surrogate Endpoints Today
January 20th, 2026
Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration
January 13th, 2026
Making Clinical Trial Technology Work in Practice